IMMUNE -FRAME Trademark

Trademark Overview


On Monday, June 23, 2025, a trademark application was filed for IMMUNE -FRAME with the United States Patent and Trademark Office. The USPTO has given the IMMUNE -FRAME trademark a serial number of 79435780. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Thursday, November 20, 2025. This trademark is owned by R.G.C.C. Holdings AG. The IMMUNE -FRAME trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical diagnosis services.
immune -frame

General Information


Serial Number79435780
Word MarkIMMUNE -FRAME
Filing DateMonday, June 23, 2025
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateThursday, November 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkIMMUNE FRAME
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical diagnosis services.

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 30, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameR.G.C.C. Holdings AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, October 30, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, November 4, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 4, 2025APPLICATION FILING RECEIPT MAILED
Monday, November 10, 2025ASSIGNED TO EXAMINER
Thursday, November 20, 2025NON-FINAL ACTION WRITTEN
Friday, November 21, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW